175 related articles for article (PubMed ID: 9584079)
21. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
Watanabe A; Takeda K; Ploplis B; Tachibana M
Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II.
Zhang H; Chen H; Luo H; An J; Sun L; Mei L; He C; Jiang L; Jiang W; Xia K; Li JD; Feng Y
Hum Genet; 2012 Mar; 131(3):491-503. PubMed ID: 21965087
[TBL] [Abstract][Full Text] [Related]
23. Three novel PAX3 mutations observed in patients with Waardenburg syndrome type 1.
Soejima H; Fujimoto M; Tsukamoto K; Matsumoto N; Yoshiura KI; Fukushima Y; Jinno Y; Niikawa N
Hum Mutat; 1997; 9(2):177-80. PubMed ID: 9067759
[No Abstract] [Full Text] [Related]
24. Two different PAX3 gene mutations causing Waardenburg syndrome type I.
Wildhardt G; Winterpacht A; Hilbert K; Menger H; Zabel B
Mol Cell Probes; 1996 Jun; 10(3):229-31. PubMed ID: 8799378
[TBL] [Abstract][Full Text] [Related]
25. Identification of two PAX3 mutations causing Waardenburg syndrome, one within the paired domain (M62V) and the other downstream of the homeodomain (Q282X).
Hol FA; Geurds MP; Cremers CW; Hamel BC; Mariman EC
Hum Mutat; 1998; Suppl 1():S145-7. PubMed ID: 9452070
[No Abstract] [Full Text] [Related]
26. Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects.
Yang T; Li X; Huang Q; Li L; Chai Y; Sun L; Wang X; Zhu Y; Wang Z; Huang Z; Li Y; Wu H
Clin Genet; 2013 Jan; 83(1):78-82. PubMed ID: 22320238
[TBL] [Abstract][Full Text] [Related]
27. A splice junction mutation in PAX3 causes Waardenburg syndrome in a South African family.
Butt J; Greenberg J; Winship I; Sellars S; Beighton P; Ramesar R
Hum Mol Genet; 1994 Jan; 3(1):197-8. PubMed ID: 8162027
[No Abstract] [Full Text] [Related]
28. Mouse models for four types of Waardenburg syndrome.
Tachibana M; Kobayashi Y; Matsushima Y
Pigment Cell Res; 2003 Oct; 16(5):448-54. PubMed ID: 12950719
[TBL] [Abstract][Full Text] [Related]
29. The incidence of deafness is non-randomly distributed among families segregating for Waardenburg syndrome type 1 (WS1).
Morell R; Friedman TB; Asher JH; Robbins LG
J Med Genet; 1997 Jun; 34(6):447-52. PubMed ID: 9192262
[TBL] [Abstract][Full Text] [Related]
30. Molecular and clinical characterization of Waardenburg syndrome type I in an Iranian cohort with two novel PAX3 mutations.
Jalilian N; Tabatabaiefar MA; Farhadi M; Bahrami T; Emamdjomeh H; Noori-Daloii MR
Gene; 2015 Dec; 574(2):302-7. PubMed ID: 26275939
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional analysis of a novel mutation in the PAX3 gene associated with Waardenburg syndrome type I.
Niu Z; Li J; Tang F; Sun J; Wang X; Jiang L; Mei L; Chen H; Liu Y; Cai X; Feng Y; He C
Gene; 2018 Feb; 642():362-366. PubMed ID: 29158168
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and molecular genetic investigation of Waardenburg syndrome type 1].
Markova TG; Megrelishvilli SM; Shevtsov SP; Shvarts EI
Vestn Otorinolaringol; 2003; (1):17-9. PubMed ID: 12666593
[TBL] [Abstract][Full Text] [Related]
33. Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?
Gad A; Laurino M; Maravilla KR; Matsushita M; Raskind WH
Am J Med Genet A; 2008 Jul; 146A(14):1880-5. PubMed ID: 18553554
[TBL] [Abstract][Full Text] [Related]
34. Septo-optic dysplasia and WS1 in the proband of a WS1 family segregating for a novel mutation in PAX3 exon 7.
Carey ML; Friedman TB; Asher JH; Innis JW
J Med Genet; 1998 Mar; 35(3):248-50. PubMed ID: 9541113
[TBL] [Abstract][Full Text] [Related]
35. A family with unusual Waardenburg syndrome type I (WSI), cleft lip (palate), and Hirschsprung disease is not linked to PAX 3.
Pierpont JW; St Jacques D; Seaver LH; Erickson RP
Clin Genet; 1995 Mar; 47(3):139-43. PubMed ID: 7634536
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype correlations in type 1 Waardenburg syndrome.
Lalwani AK; Mhatre AN; San Agustin TB; Wilcox ER
Laryngoscope; 1996 Jul; 106(7):895-902. PubMed ID: 8667990
[TBL] [Abstract][Full Text] [Related]
37. Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes.
Farrer LA; Arnos KS; Asher JH; Baldwin CT; Diehl SR; Friedman TB; Greenberg J; Grundfast KM; Hoth C; Lalwani AK
Am J Hum Genet; 1994 Oct; 55(4):728-37. PubMed ID: 7942851
[TBL] [Abstract][Full Text] [Related]
38. Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variation.
Asher JH; Harrison RW; Morell R; Carey ML; Friedman TB
Genomics; 1996 Jun; 34(3):285-98. PubMed ID: 8786127
[TBL] [Abstract][Full Text] [Related]
39. Phenotypic variation in Waardenburg syndrome: mutational heterogeneity, modifier genes or polygenic background?
Pandya A; Xia XJ; Landa BL; Arnos KS; Israel J; Lloyd J; James AL; Diehl SR; Blanton SH; Nance WE
Hum Mol Genet; 1996 Apr; 5(4):497-502. PubMed ID: 8845842
[TBL] [Abstract][Full Text] [Related]
40. PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse.
Tassabehji M; Newton VE; Leverton K; Turnbull K; Seemanova E; Kunze J; Sperling K; Strachan T; Read AP
Hum Mol Genet; 1994 Jul; 3(7):1069-74. PubMed ID: 7981674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
